Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, August 31, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

FDA Grants Breakthrough Designation for Multiple Myeloma Drug
Tuesday, May 20, 2014
Bristol-Myers Squibb and AbbVie received the designation for Elotuzumab, an investigational humanized monoclonal antibody for multiple myeloma.

Prostrate Cancer Drug Moves into Human Clinical Trials
Monday, May 19, 2014
ADC Therapeutics announced that it has selected its first IND candidate under its joint development agreement with MedImmune.

PsiOxus to Release Study Results of Oncolytic Vaccine Enadenotucirev
Saturday, May 17, 2014
Phase I studies to be presented at 2014 ASCO annual meeting.

Complix Appoints Dr Yvonne McGrath as CSO
Saturday, May 17, 2014
Dr McGrath will be responsible for the use of the Company´s Alphabody platform.

Novasep’s €4 M ADC Manufacturing Plant Extension Commissioned
Friday, May 16, 2014
The new Highly Potent API manufacturing capacity at the Le Mans facility will boost Novasep’s ability to meet customer demand for producing anti-cancer therapies.

Decline in Whooping Cough Cases Continues
Friday, May 16, 2014
PHE publish whooping cough figures which are on a decline across England.

Veeco Appoints Shubham Maheshwari as Chief Financial Officer
Friday, May 16, 2014
Mr. Maheshwari replaces David D. Glass.

Glenmark’s GBR 900 for Treatment of Chronic Pain Entering Human Trials
Thursday, May 15, 2014
The antibody has successfully completed the Phase I enabling preclinical development programme and a Phase I clinical trial application has been filed with the MHRA, UK.

MRC Technology, Daiichi Sankyo form Drug Discovery Collaboration
Wednesday, May 14, 2014
Initiative brings together global expertise to streamline drug discovery.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 1075
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv